Zobrazeno 1 - 10
of 80
pro vyhledávání: '"E. Halloran"'
Autor:
Philip R Krause, Thomas R Fleming, Susan S Ellenberg, Ana Maria Henao-Restrepo, PR Krause, T Fleming, MM Alejandria, B Bhargava, S Ellenberg, PJ Garcia, E Halloran, AM Henao-Restrepo, I Longini, MC Miranda Montoya, M Roses, H Sommerfelt
Publikováno v:
Lancet (London, England)
The Lancet
The Lancet
Publikováno v:
Epidemiology and Infection
SUMMARYAn individual's risk of infection from an infectious agent can depend on both the individual's own risk and protective factors and those of individuals in the same community. We hypothesize that an individual's exposure to an infectious agent
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Marc Bekoff, Margaret E. Halloran
Publikováno v:
Ethology. 97:236-248
Nesting behaviour of Abert squirrels (Sciurus aberti), including site selection and use, was studied in the foothills of the Rocky Mountains in Boulder County, Colorado. Only females were observed building nests, although both males and females maint
Autor:
W. Cao, J. Hu, E. Chen, S. Liang, Ye Zhang, Yang Yang, M. E. Halloran, Eben Kenah, Tom Britton, Fenyang Tang, Li Qun Fang, Zijian Feng, Ira M. Longini, M. Ma
To study human-to-human transmissibility of the avian influenza A (H7N9) virus in China, household contact information was collected for 125 index cases during the spring wave (February to May 2013), and for 187 index cases during the winter wave (Oc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23746fcfbe2047924974357de8639cf4
https://europepmc.org/articles/PMC4404303/
https://europepmc.org/articles/PMC4404303/
Autor:
Margaret E. Halloran
Publikováno v:
i-manager's Journal of Educational Technology. 2:73-101
Autor:
Marcelo F. C. Gomes, Ira M. Longini, Livio Bioglio, Dennis L. Chao, A Pastore y Piontti, M. E. Halloran, Loïc Rossi, Alessandro Vespignani, Vittoria Colizza, Chiara Poletto
Publikováno v:
Eurosurveillance
Eurosurveillance, 2014, 19 (42), pp.2. ⟨10.2807/1560-7917.ES2014.19.42.20936⟩
Europe PubMed Central
Eurosurveillance, European Centre for Disease Prevention and Control, 2014, 19 (42), pp.2. ⟨10.2807/1560-7917.ES2014.19.42.20936⟩
Scopus-Elsevier
Eurosurveillance, 2014, 19 (42), pp.2. ⟨10.2807/1560-7917.ES2014.19.42.20936⟩
Europe PubMed Central
Eurosurveillance, European Centre for Disease Prevention and Control, 2014, 19 (42), pp.2. ⟨10.2807/1560-7917.ES2014.19.42.20936⟩
Scopus-Elsevier
International audience; The quick spread of an Ebola outbreak in West Africa has led a number of countries and airline companies to issue travel bans to the affected areas. Considering data up to 31 Aug 2014, we assess the impact of the resulting tra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::801ce6f5ba40acdf3736bf8414a8bae4
https://europepmc.org/articles/PMC4415609/
https://europepmc.org/articles/PMC4415609/
Autor:
Linda M. Greenwald, Laurence J. Resseguie, Samuel Zylstra, Barbara A. Ricci, Maureen Mondor, Carl J. D'Orsi, Elizabeth E. Halloran
Publikováno v:
The Breast Journal. 7:76-90
The goal of this study was to determine whether factors associated with the successful defense and cost of malpractice cases involving the failure to diagnose breast cancer could be identified in medical and legal records. Secondary goals were to dev
Autor:
M. E. Halloran
Publikováno v:
Journal of the Royal Statistical Society Series A: Statistics in Society. 161:265-272
Summary Several scientific questions are of interest in phase III trials of prophylactic human immunodeficiency virus (HIV) vaccines. In this paper we focus on some issues related to evaluating the direct protective effects of a vaccine in reducing s
Autor:
Paul A. Rota, Roy M. Anderson, A. A. Lal, P. Rosa, OraLee H. Branch, L. Gooding, M. A. Burke, Karen P. Day, Eduardo Massad, P. Wiener, Richard W. Compans, R. M. Krause, R. S. Azevedo-Neto, Sunetra Gupta, Harry L. Keyserling, D. M. T. Zanetta, Angela R. McLean, O. Kew, William J. Bellini, M. E. Halloran, S. G. Wynn, J. Katz
Publikováno v:
The American Journal of the Medical Sciences. 315:76-86
The purpose of prophylactic vaccination is to reduce morbidity and mortality in a population. Many questions related to the design of vaccines and vaccination programs require a population standpoint for their sharp formulation and laboratory and fie